Category
Evidence & Quality Guides
Product identity, evidence-boundary and analytical-quality explainers.
-
Evidence & Quality Guides
AICAR Identity Guide: Acadesine, ZMP and the AMPK Evidence Boundary
-
Evidence & Quality Guides
Cibinetide/ARA-290 Identity: The 11-Mer Sequence and Quality Record
-
Evidence & Quality Guides
NAD+ vs NADH: Identity, Measurement and Stability Guide
-
Evidence & Quality Guides
Thymalfasin Identity: Thymosin Alpha-1 Sequence and Acetylation
-
Evidence & Quality Guides
PT-141/Bremelanotide: Free Base, Acetate and Finished-Drug Boundary
-
Evidence & Quality Guides
AOD-9604 Evidence Boundary: GH Fragment Biology, Failed Development and Lot Identity
-
Evidence & Quality Guides
CJC-1295 With DAC: Albumin Binding, Identity Controls and FDA Safety Context
-
Evidence & Quality Guides
CJC-1295 Without DAC: Sequence, Naming and a Quality Checklist
-
Evidence & Quality Guides
Survodutide Research Status: Dual Glucagon/GLP-1 Biology, Trials and Material Identity
-
Evidence & Quality Guides
SS-31, Elamipretide and Forzinity: Why the Finished-Drug Distinction Matters
-
Evidence & Quality Guides
MK-677 / Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions
-
Evidence & Quality Guides
Ipamorelin Evidence and Safety: Route-Specific Data and Peptide Characterization